Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male Subjects
NCT07644442
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Mass Balance Study
Interventions
DRUG:
HMPL-453
Sponsor
Hutchmed